End‐to‐end collaboration to transform biopharmaceutical development and manufacturing
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
An ambitious 10‐year collaborative program is described to invent, design, demonstrate, and support commercialization of integrated biopharmaceutical manufacturing technology intended to transform the industry. Our goal is to enable improved control, robustness, and security of supply, dramatically reduced capital and operating cost, flexibility to supply an extremely diverse and changing portfolio of products in the face of uncertainty and changing demand, and faster product development and supply chain velocity, with sustainable raw materials, components, and energy use. The program is organized into workstreams focused on end‐to‐end control strategy, equipment flexibility, next generation technology, sustainability, and a physical test bed to evaluate and demonstrate the technologies that are developed. The elements of the program are synergistic. For example, process intensification results in cost reduction as well as increased sustainability. Improved robustness leads to less inventory, which improves costs and supply chain velocity. Flexibility allows more products to be consolidated into fewer factories, reduces the need for new facilities, simplifies the acquisition of additional capacity if needed, and reduces changeover time, which improves cost and velocity. The program incorporates both drug substance and drug product manufacturing, but this paper will focus on the drug substance elements of the program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current Standards Landscape for Smart Manufacturing Systems
Lu, Y., Morris, K., & Frechette, S. (2016) · doi:10.6028/nist.ir.8107 · Cited by 360 · cited 1×
“We envision a future where multiple small production lines are running simultaneously in a ballroom production suite, with each line comprised entirely of smart (Lu et al., 2016), off‐the‐shelf components to enable self‐validation.”
MethodRecommendations for Comparison of Productivity Between Fed‐Batch and Perfusion Processes
Bausch, M., Schultheiss, C., & Sieck, J. B. (2019) · Biotechnology Journal · doi:10.1002/biot.201700721 · Cited by 73
Patel, B. A., Gospodarek, A., Larkin, M., Kenrick, S. A., Haverick, M. A., Tugcu, N., Brower, M. A., & Richardson, D. D. (2018) · mAbs · doi:10.1080/19420862.2018.1505178 · Cited by 52
Self-citation
Cited by
The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing
Esmonde-White, K. A., Cuellar, M., & Lewis, I. R. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03727-4 · Cited by 152
“Their 10-year roadmap seeks to address manufacturing cost, robustness, improved control, and supply flexibility [17].”
BackgroundWang, J., Chen, J., Studts, J., & Wang, G. (2023) · mAbs · doi:10.1080/19420862.2023.2220149 · Cited by 37
Current GMP standards for the large‐scale production of monoclonal antibodies
Troncoso‐Bravo, T., Pavez, V., Letelier, P., Del Río, J., Anabalón, C., Peñaloza, H. F., González, P. A., Bueno, S. M., & Kalergis, A. M. (2026) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70121 · Cited by 2
Metadata
- Authors
- Erickson, J., Baker, J., Barrett, S., Brady, C., Brower, M., Carbonell, R., Charlebois, T., Coffman, J., Connell‐Crowley, L., Coolbaugh, M., Fallon, E., Garr, E., Gillespie, C., Hart, R., Haug, A., Nyberg, G., Phillips, M., Pollard, D., Qadan, M., Ramos, I., Rogers, K., Schaefer, G., Walther, J., & Lee, K.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2021-02-02
- Volume
- 118
- Issue
- 9
- Pages
- 3302-3312
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W3121467547
- Cited by
- 48
- References
- 3
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: End‐to‐end collaboration to transform biopharmaceutical development and manufacturing. https://app.cochat.ai/papers/10.1002/bit.27688
- The paper
- Erickson, J., Baker, J., Barrett, S., Brady, C., Brower, M., Carbonell, R., Charlebois, T., Coffman, J., Connell‐Crowley, L., Coolbaugh, M., Fallon, E., Garr, E., Gillespie, C., Hart, R., Haug, A., Nyberg, G., Phillips, M., Pollard, D., Qadan, M., . . . Lee, K. (2021). End‐to‐end collaboration to transform biopharmaceutical development and manufacturing. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.27688
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.